<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11864857</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.693</article-id><article-id pub-id-type="other">EPP0584</article-id><article-id pub-id-type="pii">S092493382400693X</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Comparison of Val66met Polymorphism of BDNF gene in patients of bipolar disorder and healthy controls.</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Srikantamurthy</surname><given-names>M.</given-names></name><xref rid="aff1640" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0554" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Moirangathem</surname><given-names>S.</given-names></name><xref rid="aff1641" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Viswanath</surname><given-names>B.</given-names></name><xref rid="aff1641" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Purushottam</surname><given-names>M.</given-names></name><xref rid="aff1642" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Jain</surname><given-names>S.</given-names></name><xref rid="aff1641" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="aff1640"><sup>1</sup>Department of psychiatry, <institution>Orygen youth health</institution>, <city>Melbourne</city>, <country>
Australia</country></aff><aff id="aff1641"><sup>2</sup>Department of psychiatry</aff><aff id="aff1642"><sup>3</sup>Department of molecular genetics, <institution>National Institute of Mental Health and Neurosciences</institution>, <city>Bangalore</city>, <country>
India</country></aff><author-notes><corresp id="cor0554"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="668">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S335</fpage><lpage>S336</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S092493382400693Xa.pdf"/><abstract><sec id="sec3330"><title>Introduction</title><p>The study aims to explore the utility of BDNF Val66Met polymorphism as a potential biomarker in Indian bipolar disorder patients and its correlation with clinical characteristics.</p></sec><sec id="sec3331"><title>Objectives</title><p>Genotyping Val66Met in BDNF gene</p><p>Exploring its association with bipolar disorder (BD).</p></sec><sec id="sec3332"><title>Methods</title><p>150 consenting BD patients and matched controls were recruited using a case-control study design. BD severity was assessed using Young&#x02019;s mania rating scale and the Clinical Global Impression - Severity (CGI-S) scale. BDNF Val66Met polymorphism was identified through real-time PCR after DNA extraction. Data was tested for normal distribution. Genotype frequencies between two groups were compared and the Hardy-Weinberg equilibrium assumptions were tested using Chi-Square tests. Clinical-genotypic associations were explored using the Kruskal-Wallis test and confirmed using hierarchical regression.</p></sec><sec id="sec3333"><title>Results</title><p>Our sample had more males (60%) than females (40%) with mean age of 35.05 years. Most patients had established bipolar disorder and were severely ill (CGI: 38.75, YMRS). Val66Met SNP genotype frequency differed significantly between cases and controls. Val66Val genotype and Val allele were higher in cases. Results consistent with Hardy-Weinberg equilibrium.<table-wrap position="anchor" id="tab22"><label>Table 1.</label><caption><p>Genotype frequencies of BDNF (rs6265) in cases and controls</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th align="center" colspan="4" valign="middle" rowspan="1">GENOTYPE</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">CC</th><th align="center" valign="middle" rowspan="1" colspan="1">CT</th><th align="center" valign="middle" rowspan="1" colspan="1">TT</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">CASES</td><td align="center" valign="middle" rowspan="1" colspan="1">94(62.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">47(31.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">9(6%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CONTROL</td><td align="center" valign="middle" rowspan="1" colspan="1">71(47.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">69(46%)</td><td align="center" valign="middle" rowspan="1" colspan="1">10(6.6%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CHI-SQUARE-
7.431</td><td align="center" valign="middle" rowspan="1" colspan="1">DF(Degree of freedom) - 2</td><td align="center" valign="middle" rowspan="1" colspan="1">p-value- 0.024</td><td rowspan="1" colspan="1"/></tr></tbody></table><graphic xlink:href="S092493382400693X-TABU0022" position="anchor"/></alternatives></table-wrap>
<table-wrap position="anchor" id="tab23"><label>Table 2.</label><caption><p>Dominant genotype frequencies in cases and controls</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th align="center" colspan="3" valign="middle" rowspan="1">DOMINANT GENOTYPE</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">CC</th><th align="center" valign="middle" rowspan="1" colspan="1">CT+TT</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">CASES</td><td align="center" valign="middle" rowspan="1" colspan="1">94(62.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">56(37.3%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CONTROLS</td><td align="center" valign="middle" rowspan="1" colspan="1">71(47.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">79(52.6)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CHI-SQUARE-7.125</td><td align="center" valign="middle" rowspan="1" colspan="1">DF(Degree of freedom)-1</td><td align="center" valign="middle" rowspan="1" colspan="1">p-value-0.007</td></tr></tbody></table><graphic xlink:href="S092493382400693X-TABU0023" position="anchor"/></alternatives></table-wrap>
<table-wrap position="anchor" id="tab24"><label>Table 3.</label><caption><p>Allelic frequencies of BDNF (rs6265) in BD cases and healthy controls</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th align="center" colspan="3" valign="middle" rowspan="1">ALLELIC VARIATION</th></tr><tr><th rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">C</th><th align="center" valign="middle" rowspan="1" colspan="1">T</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">CASES</td><td align="center" valign="middle" rowspan="1" colspan="1">235(78.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">65(21.6%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CONTROLS</td><td align="center" valign="middle" rowspan="1" colspan="1">211(70.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">89(29.6%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CHI-SQUARE-5.032</td><td align="center" valign="middle" rowspan="1" colspan="1">DF(Degree of freedom)-1</td><td align="center" valign="middle" rowspan="1" colspan="1">p-value- 0.024</td></tr></tbody></table><graphic xlink:href="S092493382400693X-TABU0024" position="anchor"/></alternatives></table-wrap>
</p></sec><sec id="sec3334"><title>Conclusions</title><p>Our study found that Val66Val genotype and Val allele were higher in cases and could be a potential biomarker for bipolar disorder (BD), which is consistent with previous research conducted on the European population. However, further investigations are required to gain a more comprehensive understanding of its impact on BD, including its association with serum BDNF levels, treatment outcomes, and a more diverse study population.</p></sec><sec id="sec3335"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>